Kimon V Argyropoulos

9PUBLICATIONS
64CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical mycologyMedical bacteriologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 02, 2026
Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial.

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Nov 04, 2022
Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations.

Kylee H Maclachlan, Tina Bagratuni, Efstathios Kastritis

|Dec 14, 2020
Bronchiolar Adenoma/Pulmonary Ciliated Muconodular Papillary Tumor.

Hemlata Shirsat, Fang Zhou, Jason C Chang

|Nov 08, 2019
Tumor-infiltrating and circulating granulocytic myeloid-derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides.

K V Argyropoulos, M Pulitzer, S Perez

|Nov 02, 2018
Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice.

Jennifer J Tsai, Enrico Velardi, Yusuke Shono

Pageof 2

Frequent Collaborators

4 joint publications

Ahmet Dogan

2 joint publications

Gilles Salles

2 joint publications

Lorenzo Falchi

2 joint publications

Gunjan L Shah